India MedTech Expo 2025: DoP to hold second edition from 4th to 6th September
New Delhi: The Department of Pharmaceuticals in association with the Ministry of Commerce and Industry, Export Promotion Council for Medical Devices (EPCMD), and Central Drugs Standard Control Organisation (CDSCO), Ministry of Health & Family Welfare to hold the second edition of the India MedTech Expo 2025 at Bharat Mandapam, Pragati Maidan, New Delhi from 4–6 September 2025, as part of the larger Bharat Health 2025 initiative.
Union Minister for Health & Family Welfare and Chemicals and Fertilizers Shri Jagat Prakash Nadda and Union Minister of State for Commerce & Industry and Electronics & IT, Shri Jitin Prasada will be inaugurating the event.
Shri Amit Agrawal, Secretary, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers; Shri Nitin Kumar Yadav, Additional Secretary, Department of Commerce; Mr. P. Krishnamurthy, Chairman of the National Pharmaceutical Pricing Authority (NPPA); Dr. Rajeev Singh Raghuvanshi, Drug Controller General of India (DCGI); and Shri R. P. Singh, Joint Secretary, Department of Pharmaceuticals, will be among the esteemed dignitaries participating in the event.
India MedTech Expo has emerged as a premier platform to highlight India’s capabilities and growth in the medical technology and devices sector. The 2025 edition will once again bring together policymakers, global business leaders, innovators, investors, and healthcare stakeholders, reinforcing India’s position as a hub for precision-driven, yet affordable, MedTech solutions.
The three-day expo themed as ‘India: Global MedTech Manufacturing Hub, Precision Engineering yet Affordable’ will feature an expansive exhibition showcasing MSMEs, start-ups, research institutions, future innovation pavilions, state showcases, and government initiatives.
The conclave will include thematic conferences, CEO roundtables, fireside chats, and state-focused sessions, with the participation of Union and State Ministers. Experience zones and networking opportunities such as B2B meetings, Reverse Buyer-Seller Meets, and regulator open houses will further enable collaborations across the med-tech value chain.
Other key speakers include, Shri Rakesh Kumar Singh, CEO, YEIDA, Medical Device Park, UP; Shri Awadhesh Chaudhary, Senior Economic Advisor, Department of Pharmaceuticals; Shri Pramod Meshram, Deputy Drugs Controller (India), CDSCO IVD Division, etc.
Speaking about the upcoming edition, Mr Praveen Kumar Mittal, Executive Director, EPCMD, said, “India’s medical devices sector has grown to a market size of nearly USD 15 billion and is projected to reach USD 30 billion by 2030. With more than 800 MedTech start-ups, strong R&D capabilities, and a fast-growing manufacturing base, we are positioning India as not just a consumer market, but as a global innovation and export hub. India MedTech Expo 2025 will be the catalyst to showcase this growth story and enable collaborations that can transform healthcare access both in India and worldwide.”
The event will witness participation from over 150 international buyers representing more than 30 countries, offering a unique opportunity for global stakeholders to explore partnerships and investments in India’s rapidly expanding MedTech ecosystem.
The Expo will bring together over 350 exhibitors across specialized pavilions and host conference sessions to foster innovation and advance India’s Vision 2047 in the global MedTech sector.
